Buprenorphin-ratiopharm® 35 Mikrogramm/h Matrixpflaster Transdermales Pflaster
ratiopharm GmbH
| Packungen | ZuZa | VS | FB | AVP | Diff. | PZN |
| Buprenorphin-ratiopharm® 35µg/h 4 transd. Pfl. N1 |  |
|
|
|||
| Buprenorphin-ratiopharm® 35µg/h 5 transd. Pfl. N1 | |
|
|
|||
| Buprenorphin-ratiopharm® 35µg/h 8 transd. Pfl. | |
|
|
|||
| Buprenorphin-ratiopharm® 35µg/h 10 transd. Pfl. N2 | |
|
|
|||
| Buprenorphin-ratiopharm® 35µg/h 16 transd. Pfl. | |
|
|
|||
| Buprenorphin-ratiopharm® 35µg/h 20 transd. Pfl. N3 | |
|
|
Wirkstoffe
Weitere Bestandteile
Aloe vera, Sojabohnenöl, raffiniertes, all-rac-α-Tocopherolacetat (Ph.Eur), Styrol-Butadien-Styrol, Poly(butadien-block-styroll), Polyethylen, pigmentiert, Harz, thermoplastisch, Polyester, Drucktinte, blau
ATC-Code
N02AE01 Buprenorphin
Identa